Patents
US 11717567 B2: Vaccines against HPV and HPV-related diseases
- Granted
- 2023-08-08
- Filed
- 2021-03-08 application 17194779
- Type
- Utility · 22 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
Embodiments relate to novel vaccines against human papillomavirus (HPV) and HPV-related diseases, including multiple types of cancers. The HPV vaccines are composed of anti-human dendritic cell (DC) surface receptor antibodies, including CD40, and E6/7 proteins of HPV16 and 18. The technology described is not limited to making vaccines against HPV16- and HPV18-related diseases and can be applied to making vaccines carrying E6/7 from any type of HPV. The HPV vaccines described can target DCs, major and professional antigen presenting cells (APCs), and can induce and activate potent HPV E6/7-specific and strong CD4+ and CD8+ T cell responses. The HPV vaccines can be used for the prevention of HPV infection and HPV-related diseases as well as for the treatment of HPV-related diseases, including cancers.
Source: PVGPATDIS, file of 2026-04-10 (ipg230808.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| BAYLOR RESEARCH INSTITUTE 79 patents | US company or organization | Dallas, TX | BAYLOR RESEARCH INSTITUTE State business registration EXACT high confidence: identical full name and state BAYLOR RESEARCH INSTITUTE Nonprofit EXACT high confidence: identical full name and state | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| SangKon Oh | Baltimore, MD | 31 | PVGPATDIS, file of 2026-04-10 | |
| Sandra Zurawski | Midlothian, TX | 34 | PVGPATDIS, file of 2026-04-10 | |
| Gerard Zurawski | Midlothian, TX | 43 | Person page FUZZY high confidence | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| A61K | Preparations for medical, dental or toiletry purposes | A61K39/12 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P31/12 | PVGPATDIS, file of 2026-04-10 |
| C07K | Peptides | C07K14/005 | PVGPATDIS, file of 2026-04-10 |
| C12N | Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media | C12N7/00 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2021-03-08 | Assignment Assignment of assignor's interest | OH, SANGKON signed 2016-08-17 ZURAWSKI, SANDRA signed 2016-08-18 ZURAWSKI, GERARD signed 2016-08-23 | BAYLOR RESEARCH INSTITUTE DALLAS, TX | 55521/253 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.